Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-08
Description
The present notice serves to conclude agreements with pharmaceutical companies in accordance with Section 130a, Paragraph 8, Sentence 1, SGB V. The invitation to participate is addressed only to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs, in accordance with Section 4, Paragraph 18, of the German Medicines Act. This is not an Open Procedure in accordance with Section 15 of the VgV in conjunction with Section 119, Paragraph 3, of the GWB, but rather a publication of the invitation to conclude/join discount contracts with conditions fixed for all participants and non-negotiable, including the level of the discount. There can be an unlimited number of contractual partners, which can be pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs in accordance with Section 4, Paragraph 18, of the German Medicines Act.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – 1/DLII6/VM131 - RV div. Arzneimittel
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyPharmaceutical productsDeadline in 8 daysPublished on Nov 12, 2026
Germany – Orthopaedic implants – Endoprothetik 2026
Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH und der AGKAMED GmbHGermanyOrthopaedic implantsNo deadline givenPublished on Nov 12, 2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 bzw. § 130c Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV95
GWQ ServicePlus AGGermanyPharmaceutical productsDeadline in 268 daysPublished on Nov 12, 2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
KKH Kaufmännische KrankenkasseGermanyPharmaceutical productsDeadline in 26,709 daysPublished on Nov 12, 2026